MedTrace Logo

Metabolic Profile as a Predictor of No-reflow in Diabetic Patients

NCT04835207 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2021-04-08

No results posted yet for this study

Summary

to find metabolic factors that correlate with the development of no-reflow phenomenon that may help prevent its occurrence

Conditions

  • Acute Myocardial Infarction (AMI)

Interventions

OTHER

1- LDL-C (low-density lipoprotein cholesterol)| and HDL-C(high-density lipoprotein cholesterol) Ratio. 2- Glycemia will be assessed : RBS ( random blood sugar ) . 3- S

Blood samples were obtained before PCI, and the following parameters will be measured: 1- LDL-C (low-density lipoprotein cholesterol)\| and HDL-C(high-density lipoprotein cholesterol) Ratio. 2- Glycemia will be assessed : RBS ( random blood sugar ) . 3- S

Sponsors & Collaborators

  • El Zahraa Gamal

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-30
Primary Completion
2022-04-30
Completion
2022-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04835207 on ClinicalTrials.gov